As of 2025-12-27, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 41.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.33 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 12372.5%.
The range of the Relative Valuation is 25.16 - 52.85 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 25.0x | 21.5x |
| Forward P/E multiples | 17.9x - 18.3x | 18.1x |
| Fair Price | 25.16 - 52.85 | 41.16 |
| Upside | 7523.0% - 15914.8% | 12372.5% |
| Date | P/E |
| 2025-12-24 | 0.32 |
| 2025-12-23 | 0.32 |
| 2025-12-22 | 0.24 |
| 2025-12-19 | 0.21 |
| 2025-12-18 | 0.16 |
| 2025-12-17 | 0.11 |
| 2025-12-16 | 0.07 |
| 2025-12-15 | 0.43 |
| 2025-12-12 | 0.39 |
| 2025-12-11 | 0.36 |
| 2025-12-10 | 0.36 |
| 2025-12-09 | 0.36 |
| 2025-12-02 | 0.50 |
| 2025-11-26 | 0.36 |
| 2025-11-25 | 0.47 |
| 2025-11-24 | 0.56 |
| 2025-11-21 | 0.56 |
| 2025-11-19 | 0.56 |
| 2025-11-18 | 0.56 |
| 2025-11-17 | 0.89 |
| 2025-11-14 | 0.93 |
| 2025-11-12 | 0.93 |
| 2025-11-07 | 1.07 |
| 2025-11-06 | 0.54 |
| 2025-11-04 | 0.54 |
| 2025-11-03 | 0.52 |
| 2025-10-31 | 0.50 |
| 2025-10-30 | 0.50 |
| 2025-10-29 | 0.50 |
| 2025-10-27 | 0.54 |
| 2025-10-22 | 0.72 |
| 2025-10-21 | 0.72 |
| 2025-10-20 | 0.92 |
| 2025-10-13 | 1.07 |
| 2025-10-09 | 1.14 |
| 2025-10-03 | 2.15 |
| 2025-10-02 | 2.15 |